Adding to the confusion, GSDMD-global knockout has previously been shown to increase myeloid cell expansion and accelerate lupus phenotypes in TLR7 agonist- or pristane-induced lupus models [13], which actually coincide with our phenotypic conclusions. Here, GSDMD is linked to systemic lupus erythematosus.